Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma

Kai Fu, Dennis D. Weisenburger, William W.L. Choi, Kyle D. Perry, Lynette M. Smith, Xinlan Shi, Christine P. Hans, Timothy C. Greiner, Philip J. Bierman, R. Gregory Bociek, James O. Armitage, Wing C. Chan, Julie M. Vose

Research output: Contribution to journalArticlepeer-review

239 Scopus citations

Fingerprint Dive into the research topics of 'Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences